Aquatic Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63,242	Closed	-$480K	–	1412
2025 Q3	$480K	Sell	63,242 -144,532	-70%	-$1.2M	0.01%	880
2025 Q2	$1.86M	Buy	+207,774	New	+$1.93M	0.04%	490
2025 Q1	–	Sell	-55,890	Closed	-$420K	–	1271
2024 Q4	$420K	Sell	55,890 -80,210	-59%	-$609K	0.01%	758
2024 Q3	$1.03M	Buy	136,100 +122,400	+893%	+$930K	0.03%	496
2024 Q2	$84.7K	Buy	13,700 +10,400	+315%	+$57.4K	﹤0.01%	927
2024 Q1	$16.8K	Sell	3,300 -200	-6%	-$1.13K	﹤0.01%	1113
2023 Q4	$21K	Sell	3,500 -61,100	-95%	-$354K	﹤0.01%	1213
2023 Q3	$457K	Buy	64,600 +35,800	+124%	+$257K	0.02%	499
2023 Q2	$203K	Buy	28,800 +7,800	+37%	+$62.6K	0.01%	661
2023 Q1	$175K	Sell	21,000 -7,600	-27%	-$73.2K	0.01%	622
2022 Q4	$328K	Buy	28,600 +22,000	+333%	+$274K	0.02%	614
2022 Q3	$83K	Buy	6,600 +5,600	+560%	+$72.1K	0.01%	801
2022 Q2	$11K	Buy	+1,000	New	+$10.3K	﹤0.01%	951